Document is current
Any future updates will be listed below
-
Authors
Terra, Rafik
Thiant, Stéphanie
Claveau, Jean-Sébastien
Roy, Jean https://orcid.org/0000-0002-7716-6864
Ahmad, Imran https://orcid.org/0000-0003-1899-0164
LeBlanc, Richard https://orcid.org/0000-0001-9990-2183
-
Funding
Funding for this research was provided by:
Myeloma Canada Chair of Unieristy of Montreal
Maryse and William Brock Chair in applied research into stem cell
- License Information
-
More Information
Article History
Received: 20 March 2025
Revised: 24 April 2025
Accepted: 1 May 2025
First Online: 17 May 2025
Competing interests
: RL: consultancy for J&J, Amgen, Sanofi, Pfizer, Forus Therapeutics and GSK; honoraria from Janssen and Pfizer; research grants from Sanofi and Amgen; educational grant from Pfizer. IA: consultancy for AbbVie, Jazz Pharmaceuticals, Medexus, Sanofi, Vertex Pharmaceuticals. JR.: consultancy for Amgen, Sanofi, Janssen, and Forus Therapeutics. RT, ST and JSC: no conflict of interests.
